TriSalus Life Sciences (TLSIW) Gains from Investment Securities (2022 - 2025)
TriSalus Life Sciences posted quarterly Gains from Investment Securities of $2.4 million for Q4 2025, down 80.41% year-on-year from $12.4 million in Q4 2024, and up 195.88% on a QoQ basis from -$2.5 million in Q3 2025.
TriSalus Life Sciences (TLSIW) has 4 years of Gains from Investment Securities data on file, last reported at $2.4 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 80.41% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$804000.0 (up 78.23% YoY), and the FY2025 full-year result was $16000.0, down 94.56% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $2.4 million, up from -$2.5 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $12.4 million in Q4 2024 and bottomed at -$19.9 million in Q3 2023.
- The 4-year median for Gains from Investment Securities is -$339000.0 (2023), against an average of -$1.7 million.
- The widest annual swing landed in 2023, when Gains from Investment Securities sank 443.92%; it then jumped 20491.67% in 2024.
- A 4-year view of Gains from Investment Securities shows it stood at $50000.0 in 2022, then gained by 20.0% to $60000.0 in 2023, then surged by 20491.67% to $12.4 million in 2024, then tumbled by 80.41% to $2.4 million in 2025.
- The last three Gains from Investment Securities figures came in at $2.4 million (Q4 2025), -$2.5 million (Q3 2025), and -$700000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -700,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Dec 31, 2024 | 12.36 Mn |
| Dec 31, 2024 | 12.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Dec 31, 2023 | 60,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Sep 30, 2023 | -19.90 Mn |
| Sep 30, 2023 | -19.90 Mn |
| Mar 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 5.79 Mn |
| Sep 30, 2022 | 5.79 Mn |
| Jun 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -2.39 Mn |